Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Bennett

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Toxicology and Applied Pharmacology|February 1, 1981
Kinetics of paraquat elimination in the dogG M Hawksworth, P N Bennett, D S Davies
British Medical Journal (Clinical Research Ed.)|October 20, 1984
European Ethical Review Committee: the experience of an international ethics committee reviewing protocols for drug trialsJ M Faccini, P N Bennett, J L Reid
British Journal of Clinical Pharmacology|July 1, 1987
Passage of paracetamol into breast milk and its subsequent metabolism by the neonateL J Notarianni, H G Oldham, P N Bennett
British Journal of Clinical Pharmacology|October 1, 1995
An in vitro technique for the rapid determination of drug entry into breast milkL J Notarianni, D Belk, S A Aird, et al.
Human & Experimental Toxicology|November 1, 1990
Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdoseD K Patel, A Ogunbona, L J Notarianni, et al.
Postgraduate Medical Journal|May 1, 1991
Misoprostol does not alter the pharmacokinetics of propranololP N Bennett, G C Fenn, L J Notarianni, et al.
Scandinavian Journal of Gastroenterology|January 1, 1978
Pre-medication for endoscopy. A trial of atropine, pentazocine or pethidine as a supplement to diazepamP J Cook, P N Bennett, J E Lennard-Jones, et al.
Human & Experimental Toxicology|May 1, 1990
Metabolism of aspirin after therapeutic and toxic dosesD K Patel, A Hesse, A Ogunbona, et al.
Scandinavian Journal of Gastroenterology|January 1, 1975
Effects of carbenoxolone sodium and of aspirin on gastric mucosal potential difference in normal subjectsP N Bennett, G M Frigo, W M Weerasinghe, et al.
British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Toxicology and Applied Pharmacology|February 1, 1981
Kinetics of paraquat elimination in the dogG M Hawksworth, P N Bennett, D S Davies
British Medical Journal (Clinical Research Ed.)|October 20, 1984
European Ethical Review Committee: the experience of an international ethics committee reviewing protocols for drug trialsJ M Faccini, P N Bennett, J L Reid
British Journal of Clinical Pharmacology|July 1, 1987
Passage of paracetamol into breast milk and its subsequent metabolism by the neonateL J Notarianni, H G Oldham, P N Bennett
British Journal of Clinical Pharmacology|October 1, 1995
An in vitro technique for the rapid determination of drug entry into breast milkL J Notarianni, D Belk, S A Aird, et al.
Human & Experimental Toxicology|November 1, 1990
Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdoseD K Patel, A Ogunbona, L J Notarianni, et al.
Postgraduate Medical Journal|May 1, 1991
Misoprostol does not alter the pharmacokinetics of propranololP N Bennett, G C Fenn, L J Notarianni, et al.
Scandinavian Journal of Gastroenterology|January 1, 1978
Pre-medication for endoscopy. A trial of atropine, pentazocine or pethidine as a supplement to diazepamP J Cook, P N Bennett, J E Lennard-Jones, et al.
Human & Experimental Toxicology|May 1, 1990
Metabolism of aspirin after therapeutic and toxic dosesD K Patel, A Hesse, A Ogunbona, et al.
Scandinavian Journal of Gastroenterology|January 1, 1975
Effects of carbenoxolone sodium and of aspirin on gastric mucosal potential difference in normal subjectsP N Bennett, G M Frigo, W M Weerasinghe, et al.
British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.
Pageof 5